5 minutes Get comfortable in our relaxing treatment chair
The purpose of this guide is to summarize, in plain language, the current scientific understanding of what myo-inositol is, its main mechanisms of action, the outcomes most consistently reported in peer-reviewed studies, and the practical aspects of supplementation that are supported by evidence
Patients who maintain the same injection time weekly experience smoother side effect progression than those who vary their schedule by 6+ hours week to week
If patients do not tolerate a dose during dose escalation, consider delaying dose escalation for 4 weeks The maintenance dosages of Wegovy for weight reduction in adults are 1.7 mg, 2.4 mg (recommended), or 7.2 mg (when additional weight reduction is clinically indicated) injected subcutaneously once weekly
When taken, it works as a glucagon-like peptide-1 (GLP-1) receptor agonist